Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Germantown, Maryland
- Most recent report
- 10-Q, filed Aug 4, 2026
- Incorporated
- Virginia
- Filings on record
- 1,001+ filings
- On EDGAR
- CIK 1356090
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer, Smaller reporting company
Financials 8 of 47
News 8 of 136
Prospectuses and Registrations 8 of 33
- S-3 Shelf registration statement Aug 19, 2025
- 424B5 Prospectus supplement for an offering Aug 8, 2024
- 424B5 Prospectus supplement for an offering Aug 6, 2024
- S-3 Shelf registration statement Dec 29, 2023
- S-8 Registration statement for an employee plan Jul 6, 2023
- 424B5 Prospectus supplement for an offering Jan 26, 2023
- 424B5 Prospectus supplement for an offering Jan 24, 2023
- 424B5 Prospectus supplement for an offering Aug 9, 2022
Proxies 8 of 25
- DEFA14A Extra proxy material Apr 30, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 30, 2026
- DEFA14A Extra proxy material May 16, 2025
- DEF 14A Proxy statement for a shareholder vote May 16, 2025
- PRE 14A Preliminary proxy statement May 6, 2025
- DEF 14A Proxy statement for a shareholder vote May 28, 2024
- DEFA14A Extra proxy material Apr 25, 2023
- DEF 14A Proxy statement for a shareholder vote Apr 25, 2023
Ownership 8 of 719
- 4 Insider reported a trade Aug 28, 2026
- 144 Notice of a proposed sale of restricted stock Aug 26, 2026
- 4 Insider reported a trade Aug 25, 2026
- 4 Insider reported a trade Aug 25, 2026
- 4 Insider reported a trade Aug 25, 2026
- 4 Insider reported a trade Aug 25, 2026
- 4 Insider reported a trade Aug 25, 2026
- 4 Insider reported a trade Aug 25, 2026
Other 8 of 41
- ARS Annual report sent to shareholders Apr 30, 2026
- EFFECT Notice that a registration became effective Sep 19, 2025
- CORRESP Reply to SEC staff Sep 17, 2025
- UPLOAD Comment letter from SEC staff Aug 26, 2025
- ARS Annual report sent to shareholders May 16, 2025
- ARS Annual report sent to shareholders May 28, 2024
- EFFECT Notice that a registration became effective Jan 17, 2024
- CORRESP Reply to SEC staff Jan 12, 2024
Everything here comes from Precigen, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.